A New Hampshire surgeon is shedding light on the growing use of GLP-1 medications for weight loss as more Americans turn to drugs like Ozempic, Wegovy, and Zepbound to manage obesity. In a recent interview with WMUR, Dr. Robert Catania of Southern New Hampshire Weight Management discussed the benefits, risks, and rising popularity of these medications.
GLP-1 medications were originally developed to treat Type 2 diabetes, but doctors soon discovered that they also help patients lose weight by reducing appetite and slowing digestion. According to Dr. Catania, the drugs are most suitable for people with a Body Mass Index (BMI) over 30, or those with a BMI above 27 who also suffer from obesity-related conditions such as diabetes or high blood pressure.
Also Read:How to Build Daily Mental Health Habits That Work
The popularity of GLP-1 drugs has surged in recent years, fueled by celebrity endorsements and social media discussions. Health experts say the medications can lead to significant weight loss, with some patients losing up to 20% of their body weight. However, doctors warn that the drugs are not intended for people trying to lose only a few pounds.
Despite their effectiveness, GLP-1 medications also come with concerns. Common side effects include nausea, vomiting, constipation, and diarrhea. Experts also stress the importance of maintaining healthy eating habits and regular exercise while using the drugs to avoid muscle loss and nutritional deficiencies.
Dr. Catania emphasized that GLP-1 medications should be used under medical supervision and viewed as part of a long-term weight management plan rather than a quick fix. As demand continues to grow, healthcare professionals are urging patients to understand both the benefits and risks before starting treatment.
also Read: health news
